Blue Horseshoe Stocks

ARNA, VHGI, EVDR, TWHI & Today’s Extended Watchlist

Arena Pharmaceuticals, Inc. ARNA

With only a couple of sessions remaining before ARNA’s FDA date, we are watching this stock as closely as ever. We expect to see a significant amount of volatility from the stock this week, as we keep our eyes peeled for new press.

No matter how this all shakes out, we will want to keep ARNA on a short leash heading into the FDA date, as there are no guarantees to its performance, FDA approval or not. As we stated on Friday, smart traders may have already taken some profits off of the table.

VHGI Holdings, Inc. VHGI

We first mentioned VHGI on December 9th, and on that day, we saw a great run totaling nearly 100% from .21-.40. By January the 23rd, that high increased nearly two-fold again, running up to .746.

On Friday the stock saw abnormally high volume coupled with the 52-week low, prompting us to put VHGI back on our watchlist in anticipation of an eventual bounce. All in all, we feel the recent selloff as a new opportunity with this stock.

Evader, Inc. EVDR

We first alerted EVDR on May 2nd. On May 3rd, it hit a high of .003, yielding us a rapid 150% overnight gain!

We have witnessed EVDR’s ability to make significant leaps in just a short time period, and will thus be monitoring closely for the next wave of activity.

Thwapr, Inc. THWI

Although THWI didnt put up the performance we hoped for last week, it did hold support at .026

We noticed some newsletter coverage over the weekend from various emailers, and look forward to seeing the actvity resulting from heightened awareness.

Extended Watchlist:

ECDC, PROP, VPER, BKW,

Arena Pharmaceuticals, Inc. – ARNA & Today’s Extended Watchlist

Arena Pharmaceuticals, Inc. ARNA

ARNA has been on an unstoppable run since we’ve had it appear in our newsletters. Even in uncertain times with the market, with the Dow being down more than 200pts yesterday, ARNA continued to push forward, gaining another 11%

That brings the total gain we’ve pulled in from ARNA to 112% in just over a month’s time. There are certainly no guarantees that ARNA will receive the FDA approval that everyone seems to be anticipating. Some would say now is the time to lock in those profits before the results are in, for failure to attain FDA approval could send this stock into a downward spiral.

We’ve even considered the idea of playing puts on ARNA options should things get a little ugly from here. $5 & $7 Puts would be multi-bag winners if the stock should fall to the 2.00 range, a distinct possibility if FDA approval isn’t awarded.

On the flipside, straddling the stock by purchasing both a Call and a Put could mitigate our risk in the event that FDA approval is forthcoming. For example, the $15 Calls were trading at .83 yesterday, and the $5 Puts closed at .38. ($7 closed @ .65) which will be even cheaper if the stock gaps up this morning as it appears to be doing.

___

Extended Watchlist:

THWI, USNL, EEDG, RENU

RENU – Renuen Corp. & Today’s Extended Watchlist

Renuen Corp RENU

RENU has appeared in our newsletter and on our extended watchlist over the past couple of months.

In May, we saw it run from a low of .0016 to a high of .0073, for a 356% gain. Following that run, we experienced a consolidation, where RENU found support in the low .002’s.

Yesterday the stock began to perk its head up, hitting a high of .004. The key to the session was the breaking of the 50 & 100DMA, (.0033 & .0034).

RENU is receiving a “Buy” Rating from Barchart.com

We feel that the indicators are setting up the possibility for another big run, so we will want to remain vigilant, and keep RENU on our radars.

____

Extended Watchlist:
ICPA, AAPT, THWI, ARNA, ACI

WEST, THWI, ACI & Today’s Extended Watchlist

Westinghouse Solar, Inc. WEST

WEST appeared on our extended watchlist Monday for the first time, and the stock turned in a great performance. From the low of .211 to the high of .30, the stock managed a gain of 42%

It’s always nice when a pick pays almost instant dividends. We are certainly going to leave WEST on our active watchlist for the foreseeable future.

This, on the heels of Monday’s exciting announcement, stating that “CBD Energy and Westinghouse Solar Received 5MW Order From Australia’s Largest Whitegoods, Electrical Retailer, Harvey Norman, Commercial Division”

The Order for Five Megawatts exceeded the value of the company’s total shipments for 2011.

____

Thwapr, Inc. THWI

THWI appears to be ripe for a rebound . We have been pounding the table on this play since last week, which was the perfect opportunity to get in cheaply as the stock had dipped to .026.

THWI has held a higher lows both days this week, at .029, leading us to believe that this consolidation period has almost run its course.

Yesterday the stock ran into a little resistance just shy of the 20DMA (.037), but once that level is breached, it would be no surprise to us if it were to continue on to test previous areas of resistance at .06 and .08, as we’ve pointed out on the chart below.

____

Arch Coal, Inc. ACI

ACI continued its recovery yesterday, stacking up some additional gains from where we first spotted it in our alert at 6.07 on Monday. Yesterday’s high of 6.49 respresents a modest gain of 7% from our initial flag. As we stated in that alert, we are looking at this play more for its longer-term potential, however, we believe it has short-to-mid-term potential as well.

The stock closed above a key resistance point (the 20DMA of 6.43), which we view as a healthy indicator. We’d like to see ACI hold above that 20DMA, we will maintain our bullish opinion of ACI.

____

Extended Watchlist:

AAPT, ARNA, COIN, FEGR

ACI, OMVE, ENTB & Today’s Extended Watchlist

Arch Coal, Inc. ACI

ACI was a good addition to yesterday’s midday report, and once again, we come through with impeccable timing. We took notice of the fact that the stock is trending up off of its 52-week low, and wasted little time in bringing it to you.

At the time of publication, ACI was slightly in the green, trading at 6.07. ACI went on to finish the day with strength, gaining another 2.5%, closing at 6.19. We will most likely be keeping ACI on our long-term watchlist. Big Board plays can take longer to see gains of the magnitude that we often see in the OTC market. Patience is key!
____

Entest BioMedical Inc. ENTB

Our abiltiy to keep our ear to the street, and time plays with great regularity is almost uncanny. ENTB has proven that, having gained 125% for our readers in just two short trading sessions.

Friday, we added it to the newsletter to watch for a bounce after consolidation from its previous run offered a prime entry at .01 on both Friday, and Monday. On Monday, the stock performed well all day, and closed at the high-of-day; leading us to believe that the momentum could spill over into today.

We will be watching to see where ENTB encounters its next resistance point, which, on the chart, looks like it could be .042; a previous high reached in May. Higher highs and higher lows confirm an uptrend, and we will be looking for a continuation of that into today’s session.

Omni Ventures, Inc. OMVE

As is often the case, we cover plays well in advance of other groups. Such is the case with OMVE as well. After the market close yesterday, our inbox began flooding with several paid newsletters touting OMVE. Fridays low of .13, and yesterdays low of .1435 offered some great entry points to our readers ahead of the crowd. Today we could see an increased amount of activity due to the increased exposure OMVE recieved overnight.

Keep in mind that there are several paid promoters covering this play, and where there are paid promoters, there is likely a third-party selling shares to cover the costs of the campaign, which could put pressure on the stock.

If OMVE gets enough momentum, and can break above resistance points at .20, we could see some additional gains. If you were able to catch the bottom on Friday, or Monday, you could be looking at gains of 30-44% already, at yesterdays close of .187.

Certainly nothing to complain about, and definately time to consider locking in profits if it can’t break through resistance. Moving forward we want to see the support increase, and we would like to see OMVE hold higher highs and higher lows in order to remain on our watchlist.

Yesterday’s News:
PRVCY Expands and Diversifies Customer Base

____